These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1011896)

  • 1. [Interference of rifampicin on liver cytology].
    Bertelli A; Tongiani R; Chieli E; Malvaldi G
    Med Chir Dig; 1976 May; 5(6):345-8. PubMed ID: 1011896
    [No Abstract]   [Full Text] [Related]  

  • 2. [The liver and rifampicin].
    Piéron R; Marien C; Jagueux M
    Cah Med; 1973 Jun; 14(6):447-51. PubMed ID: 4766668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of rifampicin in tuberculous patients with liver diseases].
    Pozzi E; Menghini P
    G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effects of rifampicin].
    Fontagne J
    Therapie; 1973; 28(1):181-5. PubMed ID: 4731481
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 7. [The liver and rifampicin].
    Blanchon P; Paillas J; Holler A; Groseille Y; Blanchon B; Blanchon F
    Poumon Coeur; 1973; 29(6):739-52. PubMed ID: 4370583
    [No Abstract]   [Full Text] [Related]  

  • 8. [The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies].
    Salvati F; Mugnaini L; Altieri AM; De Marinis F
    Clin Ter; 1979 Jan; 88(1):45-50. PubMed ID: 436377
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepato-biliary effects of rifampicin in rats].
    Rozé C; Camilleri JP; Vaille C; Souchard M; Debray C
    Med Chir Dig; 1976 May; 5(6):373-7. PubMed ID: 1011900
    [No Abstract]   [Full Text] [Related]  

  • 11. [The results of liver biopsies during rifampicin therapy (author's transl)].
    Kozma D; Lapis K; Tompa A
    Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
    Macquet V; Lafitte P; Rogeaux Y
    Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
    Fokina LV; Vusygina RN; Antosik OD
    Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on the efficiency of rifampicin in biliary pathology].
    Arias Vallejo E; Güemes Díaz JF; Verdú Bellod JF
    Rev Clin Esp; 1973 Jun; 130(1):65-70. PubMed ID: 4755587
    [No Abstract]   [Full Text] [Related]  

  • 16. [Jaundice during rifampicin treatment].
    Ollagnier C; Vallon C
    J Med Lyon; 1971 May; 52(120):835-6 passim. PubMed ID: 5136252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepato-toxic risk of rifampicin].
    Emerit J
    Sem Hop Ther; 1976; 52(5-6):311-3. PubMed ID: 968493
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and hepatic puncture biopsy].
    Bonneau H; Girbal JP; Alibert R; Varette I; Taranger J; Chambourlier P
    Mars Med; 1970; 107(10):800-1. PubMed ID: 5476974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side effects in strictly supervised treatment with rifampicin and ethambutol].
    Năstase M; Năstase R; Brener E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):241-3. PubMed ID: 174182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.